A citation-based method for searching scientific literature

Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Silvio E Inzucchi. N Engl J Med 2015
Times Cited: 5710



John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg, Michael R Zile. N Engl J Med 2014
Times Cited: 3180




List of shared articles



Times cited

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
Frank L J Visseren, François Mach, Yvo M Smulders, David Carballo, Konstantinos C Koskinas, Maria Bäck, Athanase Benetos, Alessandro Biffi, José-Manuel Boavida, Davide Capodanno,[...]. Eur J Prev Cardiol 2022
18

Reverse remodeling in diabetic cardiomyopathy: the role of extracellular matrix.
Ibrahim Aykac, Bruno K Podesser, Attila Kiss. Minerva Cardiol Angiol 2022
1

Newer Drugs to Reduce High Blood Pressure and Mitigate Hypertensive Target Organ Damage.
Bharathi Upadhya, Patrick M Kozak, Richard Brandon Stacey, Ramachandran S Vasan. Curr Hypertens Rep 2022
1

Opportunistic screening for asymptomatic left ventricular dysfunction in type 2 diabetes mellitus.
Mi Zhou, Duo Huang, Yangyang Cheng, Yee Man Lau, Wing Hon Lai, Yuk-Ming Lau, JoJo Hai, Chu Pak Lau, Esther W Chan, Wen Sheng Yue,[...]. Postgrad Med J 2022
0

Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options.
Begum Yetis Sayin, Ali Oto. Cardiol Ther 2022
0

Vericiguat in Heart Failure with a Reduced Ejection Fraction: Patient Selection and Special Considerations.
Hayah Kassis-George, Nathan J Verlinden, Sheng Fu, Manreet Kanwar. Ther Clin Risk Manag 2022
0

Current and emerging drug targets in heart failure treatment.
Nicolò Ghionzoli, Francesco Gentile, Anna Maria Del Franco, Vincenzo Castiglione, Alberto Aimo, Alberto Giannoni, Silvia Burchielli, Matteo Cameli, Michele Emdin, Giuseppe Vergaro. Heart Fail Rev 2022
2

Cardiorenal disease in the United States: Future health care burden and potential impact of novel therapies.
Phil McEwan, Angharad R Morgan, Rebecca Boyce, Natalie Green, Bruce Song, Joanna Huang, Klas Bergenheim. J Manag Care Spec Pharm 2022
2

INDY as a Therapeutic Target for Cardio-Metabolic Disease.
Dominik Pesta, Jens Jordan. Metabolites 2022
0

Heart Failure and Drug Therapies: A Metabolic Review.
Frank Yu, Bianca McLean, Mitesh Badiwala, Filio Billia. Int J Mol Sci 2022
1

Hemodynamic arterial changes in heart failure: a proposed new paradigm of "heart and vessels failure".
Giuseppe Galati, Olga Germanova, Renato V Iozzo, Simone Buraschi, Yurii V Shchukin, Andrey Germanov, Vladimir Germanov, Olga Tereshina, Michele Senni, Alberto Margonato. Minerva Cardiol Angiol 2022
1